Hydrochlorothiazide

Rank #281 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$42.4M

Total Cost

Share:

7,879,021

Total Claims

$42.4M

Total Cost

108,281

Prescribers

$5

Cost per Claim

2,272,504

Beneficiaries

19,752,639

30-Day Fills

$392

Avg Cost/Provider

73

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$42.4M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $42.4M total

🔎 Data Overview

At $5.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Hydrochlorothiazide

#ProviderSpecialtyLocationClaimsCost
1Jose GomezInternal MedicinePonce, PR1,503$8,709
2Humberto MachadoCardiologyCoral Gables, FL1,328$7,595
3Miguel Rodriguez BurgosCardiologyJuncos, PR1,580$7,239
4Terence FrinksFamily PracticeTucker, GA1,304$6,652
5Aleksey KamenetskyCardiologyBrooklyn, NY1,082$6,433
6Gregory SingerCardiologyRochester, NY754$6,374
7Ajay MekaInternal MedicineSanta Ana, CA889$6,320
8Najmuddin KarimjeeInternal MedicineHouston, TX1,192$6,261
9Michael SatchellFamily PracticeAlbany, GA1,345$6,106
10Ramon PereaCardiologySan Juan, PR764$5,864
11Tao DuongCardiologyWestminster, CA447$5,863
12David Hernandez-RodriguezInternal MedicinePerris, CA497$5,168
13Anastasia NikitinaCardiologyNew York, NY801$5,041
14Todd FulcherFamily PracticeJackson, MS1,074$4,982
15Elliot MelecioInternal MedicineVega Alta, PR534$4,950

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
278Hydralazine Hcl (Hydralazine Hcl)$43.2M2,256,779
279Leuprolide Acetate (Lupron Depot)$42.7M9,949
280Efgartigimod Alfa-Fcab (Vyvgart)$42.6M1,005
281Hydrochlorothiazide (Hydrochlorothiazide)$42.4M7,879,021
282Tadalafil (Tadalafil)$42.3M91,082
283Topiramate (Topiramate)$41.9M1,141,093
284Latanoprostene Bunod (Vyzulta)$41.6M92,705

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology